Alexion Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 202 U.S.-traded ETFs. ALXN has around 22.2M shares in the U.S. ETF market. The largest ETF holder of ALXN is the Invesco QQQ Trust (QQQ), with approximately 2.52M shares. Investors may also find of interest that the ETF with the largest allocation to ALXN stock is VanEck Vectors Biotech ETF (BBH), with a portfolio weight of 5.05%. On average, U.S. ETFs allocate 0.43% of ALXN to their portfolios.
Additionally, ALXN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ALXN as a holding is the ProShares UltraPro QQQ (TQQQ), with a return of 99.41%.